1. Home
  2. ASYS vs NKTX Comparison

ASYS vs NKTX Comparison

Compare ASYS & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

N/A

Current Price

$13.19

Market Cap

164.5M

Sector

Technology

ML Signal

N/A

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$2.58

Market Cap

132.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASYS
NKTX
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
132.8M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ASYS
NKTX
Price
$13.19
$2.58
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$13.25
AVG Volume (30 Days)
271.8K
674.7K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
0.01
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$1,295.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$1.31
52 Week High
$18.59
$2.81

Technical Indicators

Market Signals
Indicator
ASYS
NKTX
Relative Strength Index (RSI) 49.47 58.17
Support Level $11.60 $1.95
Resistance Level $13.26 $2.74
Average True Range (ATR) 0.74 0.19
MACD 0.11 0.00
Stochastic Oscillator 59.17 59.84

Price Performance

Historical Comparison
ASYS
NKTX

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: